Novartis receives USFDA approval for Eltrombopag drug
Novartis has received USFDA approval for eltrombopag drug (Promacta for oral suspension, Novartis) for the treatment of thrombocytopenia in paediatric patients. The approval was based […]
Novartis has received USFDA approval for eltrombopag drug (Promacta for oral suspension, Novartis) for the treatment of thrombocytopenia in paediatric patients. The approval was based […]
Sun Pharmaceutical Industries has received approval from USFDA for its new drug used for acne treatment XiminoTM extended-release capsules in strengths of 45 mg, 90 […]
Dr Reddy’s Laboratories has launched generic Pramipexole dihydrochloride extended-release tablets for treatment of Parkinson’s disease in the US market. The company has launched the tablets […]
Indoco Remedies is planning an expansion programme at its sterile ophthalmic manufacturing facility in Goa with an investment of Rs. 1250 million. The company is […]
Ajanta Pharma has received final approval for its three ANDAs (Abbreviated New Drug Application) by USFDA for Montelukast tablets in the strength of 10 mg, […]
Aurobindo Pharma Ltd has received approval from the US Food & Drug Administration (USFDA) to manufacture and market Ibandronate Sodium Injection used in treatment of […]
Emcure Pharmaceuticals had been barred exports from its Hinjewadi manufacturing plant in the western state of Maharashtra. According to USFDA, the manufacturing plant does not […]
Zydus Cadila has received final approval from the USFDA to market Pyridostigmine Bromide Tablets USP, 60 mg. The tablets are used in treatment of neurological […]
Aurobindo Pharma has received USFDA approval to market Metronidazole tablets in USA. The company has received final approval from the US Food and Drug Administration […]
Dr. Reddy’s Laboratories has launched generic anti-viral Valganciclovir tablets in the US market. The company has launched Valganciclovir tablets, USP in the strength of 450 […]
Copyright © 2024 | WordPress Theme by MH Themes